Cargando…

Prognostic factors for survival in colorectal cancer patients with brain metastases undergoing whole brain radiotherapy: multicenter retrospective study

Whole brain radiotherapy (WBRT) is a mainstay of the treatment for brain metastases (BM). We evaluated prognostic factors in colorectal cancer (CRC) patients undergoing WBRT for BM. The medical records of 106 CRC patients undergoing WBRT for BM between 2000 and 2014 at three institutions were review...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koo, Taeryool, Kim, Kyubo, Park, Hae Jin, Han, Sae-Won, Kim, Tae-You, Jeong, Seung-Yong, Park, Kyu Joo, Chie, Eui Kyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062910/ https://www.ncbi.nlm.nih.gov/pubmed/32152433 http://dx.doi.org/10.1038/s41598-020-61354-y

Ejemplares similares

Radiation therapy for extrahepatic bile duct cancer: Current evidences and future perspectives
por: Koo, Taeryool, et al.
Publicado: (2019)

Impact of Mucin Proportion in the Pretreatment MRI on the Outcomes of Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy
por: Kim, Eunji, et al.
Publicado: (2019)

Post-treatment intracranial hemorrhage of brain metastases from hepatocellular carcinoma
por: Kim, Kyung Su, et al.
Publicado: (2015)

Mask dependency of the lacrimal gland dose under whole brain radiotherapy when the six‐degrees of freedom couch is not available
por: Yoon, Jai‐Woong, et al.
Publicado: (2023)

Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy
por: Koo, Taeryool, et al.
Publicado: (2015)

Molecular biomarkers in extrahepatic bile duct cancer patients undergoing chemoradiotherapy for gross residual disease after surgery
por: Koh, Hyeon Kang, et al.
Publicado: (2012)

Whole-Brain Radiotherapy vs. Localized Radiotherapy after Resection of Brain Metastases in the Era of Targeted Therapy: A Retrospective Study
por: Koo, Jaho, et al.
Publicado: (2021)

Whole brain radiotherapy with radiosensitizer for brain metastases
por: Viani, Gustavo Arruda, et al.
Publicado: (2009)

Variation in clinical target volume delineation in postoperative radiotherapy for biliary tract cancer
por: Koo, Taeryool, et al.
Publicado: (2022)

Prognostic Value of Splenic Artery Invasion in Patients Undergoing Adjuvant Chemoradiotherapy after Distal Pancreatectomy for Pancreatic Adenocarcinoma
por: Kim, Byoung Hyuck, et al.
Publicado: (2015)

A Dutch phase III randomized multicenter trial: whole brain radiotherapy versus stereotactic radiotherapy for 4–10 brain metastases
por: Hartgerink, Dianne, et al.
Publicado: (2021)

Comparison of Dose Distribution in Regional Lymph Nodes in Whole-Breast Radiotherapy vs. Whole-Breast Plus Regional Lymph Node Irradiation: An In Silico Planning Study in Participating Institutions of the Phase III Randomized Trial (KROG 1701)
por: Kim, Haeyoung, et al.
Publicado: (2020)

Radiotherapy and immune checkpoint blockades: a snapshot in 2016
por: Koo, Taeryool, et al.
Publicado: (2016)

Retrospective study of hypofractionated stereotactic radiotherapy combined with whole brain radiotherapy for patients with brain metastases
por: Xie, Xue-Yi, et al.
Publicado: (2022)

Impact of Resection Margin Distance on Survival of Pancreatic Cancer: A Systematic Review and Meta-Analysis
por: Kim, Kyung Su, et al.
Publicado: (2017)

The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer
por: Lee, Joo Ho, et al.
Publicado: (2013)

Brain metastasis in human epidermal growth factor receptor 2-positive breast cancer: from biology to treatment
por: Koo, Taeryool, et al.
Publicado: (2016)

Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
por: Jiang, Cecilia, et al.
Publicado: (2021)

Parotid gland sparing effect by computed tomography-based modified lower field margin in whole brain radiotherapy
por: Cho, Oyeon, et al.
Publicado: (2013)

Role of Postoperative Radiotherapy for Microscopic Margin Involvement in the Squamous Cell Carcinoma of Esophagus
por: Song, Sanghyuk, et al.
Publicado: (2013)

Neurocognitive function impairment after whole brain radiotherapy for brain metastases: actual assessment
por: Tallet, Agnes V, et al.
Publicado: (2012)

Multicenter analysis of stereotactic radiotherapy of the resection cavity in patients with brain metastases
por: Combs, Stephanie E., et al.
Publicado: (2018)

Effect of whole-brain radiotherapy with platinum-based chemotherapy in non-small cell lung cancer patients with multiple metastases including brain metastases
por: Ryu, Woo Kyung, et al.
Publicado: (2023)

Verification of Low Risk for Perihippocampal Recurrence in Patients with Brain Metastases Who Received Whole-Brain Radiotherapy with Hippocampal Avoidance
por: Kim, Youngkyong, et al.
Publicado: (2019)

Meta‐analysis of whole‐brain radiotherapy plus temozolomide compared with whole‐brain radiotherapy for the treatment of brain metastases from non‐small‐cell lung cancer
por: Xin, Yong, et al.
Publicado: (2018)

Interobserver variability in clinical target volume delineation in anal squamous cell carcinoma
por: Kim, Kyung Su, et al.
Publicado: (2021)

Effects of Postoperative Radiotherapy on Leptomeningeal Carcinomatosis or Dural Metastasis after Resection of Brain Metastases in Breast Cancer Patients
por: Ha, Boram, et al.
Publicado: (2017)

Randomized Trial of Erlotinib Plus Whole-Brain Radiotherapy for NSCLC Patients With Multiple Brain Metastases
por: Lee, Siow Ming, et al.
Publicado: (2014)

Upfront whole brain radiotherapy for multiple brain metastases in patients with EGFR-mutant lung adenocarcinoma
por: Li, Changhui, et al.
Publicado: (2019)

Re-Whole Brain Radiotherapy May Be One of the Treatment Choices for Symptomatic Brain Metastases Patients
por: Ono, Takashi, et al.
Publicado: (2022)

Impact of Multimodality Approach for Patients with Leptomeningeal Metastases from Solid Tumors
por: Kwon, Jeanny, et al.
Publicado: (2014)

Does Time between Imaging Diagnosis and Initiation of Radiotherapy Impact Survival after Whole-Brain Radiotherapy for Brain Metastases?
por: Nieder, Carsten, et al.
Publicado: (2013)

Advances in radiotherapy for brain metastases
por: Gondi, Vinai, et al.
Publicado: (2021)

Impact of radiation dose in postoperative radiotherapy after R1 resection for extrahepatic bile duct cancer: long term results from a single institution
por: Kim, Byoung Hyuck, et al.
Publicado: (2017)

Whole brain radiotherapy plus simultaneous in-field boost with image guided intensity-modulated radiotherapy for brain metastases of non-small cell lung cancer
por: Zhou, Lin, et al.
Publicado: (2014)

A Case of Brain Metastases from Breast Cancer Treated with Whole-Brain Radiotherapy and Eribulin Mesylate
por: Nieder, Carsten, et al.
Publicado: (2012)

Accrual to a randomised trial of adjuvant whole brain radiotherapy for treatment of melanoma brain metastases is feasible
por: Fogarty, Gerald B, et al.
Publicado: (2014)

Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy
por: Frisk, Gabriella, et al.
Publicado: (2017)

Effectiveness of temozolomide combined with whole brain radiotherapy for non‐small cell lung cancer brain metastases
por: Zhu, Ying, et al.
Publicado: (2018)

From Whole-Brain Radiotherapy to Immunotherapy: A Multidisciplinary Approach for Patients with Brain Metastases from NSCLC
por: Protopapa, Maria, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4ksj6mo649thk11jnb8qctr64i